ROS1 and non-small cell lung carcinoma: Similar to ALK rearrangements, the ROS1 rearrangements accounting for 1–2% in NSCLC could come up by ROS1 fusing with SDC4 (the other prominent partners: FIG, SLC34A2, CD74, and so on).